ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 116 filers reported holding ANAPTYSBIO INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $170,000 | -37.7% | 10,510 | +34.3% | 0.02% | -42.9% |
| Q3 2019 | $273,000 | -87.4% | 7,826 | -79.6% | 0.04% | -76.7% |
| Q2 2019 | $2,166,000 | +3.7% | 38,396 | +91.3% | 0.15% | +12.8% |
| Q1 2018 | $2,089,000 | -41.6% | 20,076 | -43.4% | 0.13% | -30.7% |
| Q4 2017 | $3,575,000 | -15.7% | 35,500 | -70.8% | 0.19% | -15.4% |
| Q3 2017 | $4,242,000 | +139.3% | 121,400 | +63.8% | 0.23% | +108.3% |
| Q2 2017 | $1,773,000 | +84.3% | 74,100 | +113.5% | 0.11% | +78.7% |
| Q1 2017 | $962,000 | – | 34,700 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |